Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Inmed Pharmaceuticals Inc (IMLFF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.30
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3870 +11.11%
on 02/26/19
0.4955 -13.22%
on 02/27/19
+0.0140 (+3.37%)
since 02/25/19
3-Month
0.2170 +98.16%
on 12/27/18
0.6270 -31.42%
on 02/05/19
+0.1900 (+79.17%)
since 12/24/18
52-Week
0.2170 +98.16%
on 12/27/18
1.3010 -66.95%
on 03/26/18
-0.7500 (-63.56%)
since 03/23/18

Most Recent Stories

More News
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology

TSX: IN OTCQX: IMLFF

IMLFF : 0.4300 (unch)
IN.TO : 0.58 (unch)
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology

TSX: IN OTCQX: IMLFF

IMLFF : 0.4300 (unch)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7429 (-4.66%)
TRLFF : 0.4400 (+3.17%)
AITB : 4.8900 (+2.95%)
BICXD : 4.5400 (-9.02%)
MMNFF : 3.3500 (+3.50%)
ATEA : 5.5000 (-2.48%)
CWBHF : 20.1035 (+0.57%)
CVSI : 6.2550 (+9.54%)
DUOT : 0.6100 (-7.58%)
CRLBF : 11.1600 (+9.43%)
ARREF : 0.7921 (-0.99%)
CLOK : 0.8200 (-4.93%)
MLCPF : 2.2354 (-3.44%)
CNBX : 0.3700 (+1.37%)
HEOFF : 0.6300 (+1.81%)
MJARF : 2.8700 (-0.35%)
ALEAF : 1.4443 (-7.40%)
OTCM : 33.5700 (-0.09%)
NUPMF : 1.8200 (-2.67%)
GLDLF : 0.7600 (-1.55%)
NMUS : 0.6500 (-9.52%)
NLST : 0.5008 (-6.39%)
GBPT : 0.5100 (unch)
IMLFF : 0.4300 (unch)
KSHB : 5.5200 (-1.95%)
CORVF : 1.6753 (-3.72%)
ELLXF : 3.1400 (+5.37%)
RSSS : 2.2400 (unch)
ISYRF : 1.1100 (unch)
FLUX : 1.3100 (-3.68%)
NWGI : 0.3500 (+16.67%)
QBIO : 1.9000 (unch)
WIZD : 0.1150 (unch)
MRMD : 3.3800 (-2.52%)
GRWG : 2.9860 (-1.13%)
BRTI : 0.2400 (-1.07%)
GTBP : 0.3838 (+2.90%)
MRIC : 2.9100 (-9.35%)
DYAI : 3.2050 (+0.79%)
GTBIF : 14.7784 (-5.27%)
MTAFF : 1.0600 (+10.19%)
EMHTF : 3.0500 (-1.93%)
ITHUF : 5.8000 (-1.70%)
ALYE : 2.5000 (-16.67%)
VTLR : 0.2000 (+17.65%)
ARHH : 1.2600 (-1.15%)
OWCP : 0.0364 (+4.00%)
STLHF : 0.6543 (-0.86%)
PPCB : 0.0135 (+16.38%)
ARTH : 0.3900 (-1.27%)
ACRGF : 22.7600 (+3.45%)
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program

Transition to INM-755 Expected to Improve the Probability of Development and Regulatory Success

IMLFF : 0.4300 (unch)
IN.TO : 0.58 (unch)
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program

Transition to INM-755 Expected to Improve the Probability of Development and Regulatory Success

IMLFF : 0.4300 (unch)
InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019

TSX:INOTCQX:IMLFF

IMLFF : 0.4300 (unch)
InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019

TSX:INOTCQX:IMLFF

IMLFF : 0.4300 (unch)
Latest Projections See Hemp CBD Markets Soaring Through 2022 and Beyond

The Brightfield Group has gotten quite a lot of ink lately for their projections that the hemp derived CBD market will outpace the "Rest of the cannabis market COMBINED". FORBES too took a look back at...

IMLFF : 0.4300 (unch)
CHOOF : 0.5300 (+1.44%)
MYM.CN : 0.550 (+3.77%)
CHOO.CN : 0.700 (unch)
TRTC : 0.9900 (+15.17%)
TRST.TO : 12.65 (-2.01%)
MYMMF : 0.4100 (+3.02%)
CTST : 9.45 (-1.87%)
InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board

TSX:INOTCQX:IMLFF

IMLFF : 0.4300 (unch)
Consumers Turn to Newly Legalized CBD Products

Hemp is known to be associated with many diverse businesses such as those involved in industrial settings, consumer textiles, and more importantly, the cannabis industry. In 2017, the majority of hemp...

IMLFF : 0.4300 (unch)
PURA : 0.0843 (-0.12%)
WCVC : 0.0414 (+3.50%)
CNAB : 0.3750 (+4.17%)
PNAT : 0.0025 (-10.71%)
WKULF : 0.0943 (-8.18%)
POT.CN : 0.125 (-3.85%)
FRLF : 0.2500 (+3.09%)
IN.TO : 0.58 (unch)
USMJ : 0.0007 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade IMLFF with:

Key Turning Points

2nd Resistance Point 0.4504
1st Resistance Point 0.4402
Last Price 0.4300
1st Support Level 0.4249
2nd Support Level 0.4198

See More

52-Week High 1.3010
Fibonacci 61.8% 0.8869
Fibonacci 50% 0.7590
Fibonacci 38.2% 0.6311
Last Price 0.4300
52-Week Low 0.2170

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar